Product Information
UCERIS 9 MG ER TABLET is a brand product labeled by Santarus Inc., priced at $57.1680 per EA under NDC 68012030930. Its NADAC has been published 524 times since Jul 23, 2014.
The High Outlier badge above means this manufacturer's average price in the budesonide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
9 mg/1
Manufacturer
Santarus Inc.NDC
68012030930
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
BUDESONIDEApproval Type
New Drug (NDA)
FDA Application
NDA203634On Market Since
1/14/2013
Pharmacological Classes
Price Statistics
The NADAC for UCERIS 9 MG ER TABLET has been published 524 times since Jul 23, 2014, and over the history we have for it it has risen 33.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $57.1680 per EA |
|---|---|
| All-time high | $57.5303 (Apr 15, 2020) |
| All-time low | $42.7462 (Aug 20, 2014) |
| 52-week high | $57.2447 |
| 52-week low | $57.1512 |
| Median price | $57.1028 |
| Average price | $54.4812 |
| Largest weekly change | +10.0% (Mar 25, 2015) |
| Weeks tracked | 524 |
| Tracking since | Jul 23, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of UCERIS 9 MG ER TABLET?
The current National Average Drug Acquisition Cost (NADAC) for UCERIS 9 MG ER TABLET, manufactured by Santarus Inc., is $57.1680 per EA (NDC 68012030930), effective Oct 1, 2025.
How has the price of UCERIS 9 MG ER TABLET changed over time?
Over the history we have for it, the NADAC for UCERIS 9 MG ER TABLET has risen 33.3%. It has been tracked across 524 weekly CMS publications since Jul 23, 2014.
What are the highest and lowest recorded NADAC prices for UCERIS 9 MG ER TABLET?
Since Jul 23, 2014, the NADAC for UCERIS 9 MG ER TABLET has ranged from a low of $42.7462 (Aug 20, 2014) to a high of $57.5303 (Apr 15, 2020), with a median of $57.1028 per EA.
Are there cheaper alternatives to UCERIS 9 MG ER TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, BUDESONIDE ER 9 MG TABLET, is $13.6545 per EA — about 76% below UCERIS 9 MG ER TABLET.
Who manufactures UCERIS 9 MG ER TABLET?
UCERIS 9 MG ER TABLET (NDC 68012030930) is labeled by Santarus Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification